US Patent 7220745 Heterocyclic compounds useful to treat HCV
Patent 7220745 was granted and assigned to Rigel Pharmaceuticals on May, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Dane Goff0
John Partridge0
Rajinder Singh0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+340 characters)
Article
Patent abstract
The present invention relates to substituted diphenyl heterocycle compounds and pharmaceutical compositions thereof that inhibit replication of HCV virus. The present invention also relates to the use of the compounds and/or compositions to inhibit HCV replication and/or proliferation and to treat or prevent HCV infections.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07220745 Heterocyclic compounds useful to treat HCV US Patent 7220745 Heterocyclic compounds useful to treat HCV
Infobox
Patent Number
072207450
Patent Number
72207450
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072207450
Date of Patent
May 22, 2007
0Patent Application Number
104403490
Date Filed
May 15, 2003
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07220745 Heterocyclic compounds useful to treat HCV
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07220745
Date of patent
May 22, 2007
Patent application number
10440349
Date Filed
May 15, 2003
Patent primary examiner
Find more entities like US Patent 7220745 Heterocyclic compounds useful to treat HCV
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.